Robin Kramer - Jul 1, 2021 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Accounting Officer
Signature
/s/ Suzanne Murray, Attorney in Fact for Robin C. Kramer
Stock symbol
BIIB
Transactions as of
Jul 1, 2021
Transactions value $
$61,759
Form type
4
Date filed
7/2/2021, 04:34 PM
Previous filing
Jun 9, 2021
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $87.6K +251 +36.15% $348.92 945 Jul 1, 2021 Direct
transaction BIIB Common Stock Tax liability -$25.8K -74 -7.83% $348.92 871 Jul 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -251 -33.25% $0.00 504 Jul 1, 2021 Common Stock 251 $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 102.902 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021.
F2 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 07/01/2020.